Lung Cancer Care
The University of Kansas Cancer Center
Precision cancer therapies for lung cancer
Among men and women in the United States, lung cancer is the 2nd most common cancer and the leading cause of cancer death. Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. In 2018, there will be an estimated 234,000 new cases of lung cancer diagnosed in the United States. At The University of Kansas Cancer Center, the region's only National Cancer Institute-designated cancer center, we take a personalized approach to lung cancer treatment and provide precision cancer therapies specific to each patient. The first step in caring for you begins the moment you call. Appointments are available within 24 hours.
Request an appointment today.
Precision cancer therapy
Our multidisciplinary team of lung cancer specialists designs effective personalized treatment for each patient based on their genetic and molecular characteristics. These precision cancer therapies integrate a patient's tumor molecular data into all treatment decisions.
Nationally renowned experts
Our fellowship-trained physicians provide the most advanced medical and surgical care for lung cancer patients, and access to nationally recognized leading-edge treatment through clinical trials. Our nationally renowned physicians/investigators conduct pivotal research that propels lung cancer care forward, leading to improved treatments and innovative patient care.